Jennifer Doudna Archives
Vanderbilt Prize winner Doudna advocates caution in human germline editing
Jul. 29, 2021—It is now possible to “edit” the human germline — the genetic cargo carried in sperm and eggs and which is passed to the next generation — in a way that snips out the mutations which cause inherited disease.
Nobel laureate Doudna set for next Discovery Lecture
Jul. 7, 2021—Nobel laureate Jennifer Doudna, PhD, winner of the 2020 Vanderbilt Prize in Biomedical Science, will deliver the next web-based Discovery Lecture on Thursday, July 22.
Vanderbilt Prize winner Doudna awarded Nobel Prize in Chemistry
Oct. 7, 2020—University of California, Berkeley, biochemist Jennifer Doudna, PhD, recipient of the 2020 Vanderbilt Prize in Biomedical Science, has been awarded the 2020 Nobel Prize in Chemistry.
Amidon named 2020 Vanderbilt Prize Student Scholar
Jul. 22, 2020—Katherine Amidon, a PhD student in the Department of Biological Sciences at Vanderbilt University, has been selected as the 2020 Vanderbilt Prize Student Scholar.
UC Berkeley’s Doudna named to receive Vanderbilt Prize
Mar. 18, 2020—Jennifer Doudna, PhD, who led development of the revolutionary genome editing technology known as CRISPR-Cas9, is the recipient of the 2020 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center announced this week.
Discovery Lecturer outlines new genome editing technique
Jan. 15, 2015—A mere 30 months since it was first described in the online edition of Science magazine, a new genome editing technique has, by many accounts, revolutionized the study of genes and disease.